Detalhe da pesquisa
1.
Two-Year Outcomes of Valoctocogene Roxaparvovec Therapy for Hemophilia A.
N Engl J Med
; 388(8): 694-705, 2023 02 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-36812433
2.
Interim analyses of the multinational real-world prospective cohort HEM-POWR study evaluating the effectiveness and safety of damoctocog alfa pegol in patients with hemophilia A.
Eur J Haematol
; 112(2): 286-295, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-37876046
3.
Long-term efficacy and safety of damoctocog alfa pegol prophylaxis in patients with haemophilia A aged 12-<18 years at enrolment into PROTECT VIII.
Acta Haematol
; 2024 Apr 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-38599195
4.
Prophylaxis use of clotting factor replacement products in people with non-severe haemophilia: A review of the literature.
Haemophilia
; 29(1): 33-44, 2023 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-36224704
5.
Confirmed long-term safety and efficacy of prophylactic treatment with BAY 94-9027 in severe haemophilia A: final results of the PROTECT VIII extension study.
Haemophilia
; 27(3): e347-e356, 2021 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-33818853
6.
PERSEPT 3: A phase 3 clinical trial to evaluate the haemostatic efficacy of eptacog beta (recombinant human FVIIa) in perioperative care in subjects with haemophilia A or B with inhibitors.
Haemophilia
; 27(6): 911-920, 2021 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-34614267
7.
Opioid exposure in haemophilia patients is common and underreported.
Haemophilia
; 26(2): 251-256, 2020 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-32100423
8.
Reversal of acquired von Willebrand syndrome with allogeneic stem cell transplant for chronic lymphocytic leukemia.
Blood Cells Mol Dis
; 77: 109-112, 2019 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-31029024
9.
The impact of obesity on chronic pain in patients with haemophilia: A multicentre retrospective analysis.
Haemophilia
; 30(2): 567-570, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38385966
10.
BAY 94-9027 prophylaxis is efficacious and well tolerated for up to >5 years with extended dosing intervals: PROTECT VIII extension interim results.
Haemophilia
; 25(6): 1011-1019, 2019 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-31621991
11.
Catheter-Related Thrombosis in Patients with Lymphoma or Myeloma Undergoing Autologous Stem Cell Transplantation.
Biol Blood Marrow Transplant
; 24(12): e20-e25, 2018 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-30053647
12.
Safety and efficacy of BAY 94-9027, an extended-half-life factor VIII, during minor surgical procedures in patients with severe haemophilia A.
Haemophilia
; 27(4): e559-e562, 2021 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-33939226
13.
Target joint resolution in patients with haemophilia A receiving long-term prophylaxis with BAY 94-9027.
Haemophilia
; 26(4): e201-e204, 2020 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-32578323
14.
Three-year outcomes of valoctocogene roxaparvovec gene therapy for hemophilia A.
J Thromb Haemost
; 2024 Apr 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-38614387
15.
Is prophylaxis required for delivery in women with factor VII deficiency?
Haemophilia
; 19(6): 827-32, 2013 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-23607277
16.
A laparoscopic approach to address massive splenomegaly, symptomatic cholelithiasis, and a planned postoperative pregnancy: A case report.
Clin Case Rep
; 11(1): e6831, 2023 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-36703775
17.
Efficacy and safety of damoctocog alfa pegol prophylaxis in patients ⩾40 years with severe haemophilia A and comorbidities: post hoc analysis from the PROTECT VIII study.
Ther Adv Hematol
; 14: 20406207231166779, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37113811
18.
Building the foundation for a community-generated national research blueprint for inherited bleeding disorders: research priorities to transform the care of people with hemophilia.
Expert Rev Hematol
; 16(sup1): 19-37, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36920859
19.
Clinical studies of extended-half-life recombinant FVIII products for prophylaxis in adults and children: A critical review from the physician's perspective.
Crit Rev Oncol Hematol
; 174: 103678, 2022 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-35390452
20.
Decreased Bleeding Rates in Patients with Hemophilia A Switching from Standard-Half-Life FVIII to BAY 94-9027 Prophylaxis.
Thromb Haemost
; 121(8): 1079-1086, 2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-33296943